Switch to:
More From Other Websites
Drugmakers May Lose $390B In Sales Over 5 Years Jun 22 2017
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA Jun 22 2017
Eosinophilic Esophagitis: Major Market Opportunity for Dupixent? Jun 20 2017
Dupixent May Prove Effective in Multiple Diseases Jun 20 2017
Horizon Pharma Gets Health Canada Approval for Procysbi Jun 20 2017
Dupixent May Be a Major Growth Driver for Regeneron in 2017 Jun 20 2017
4 Buy-Ranked Large Cap Pharma Stocks to Add to Your Portfolio Jun 20 2017
Regeneron’s Praluent May See Gradual Increase in 2017 Demand Jun 20 2017
Sanofi: Should Value Investors Consider SNY Stock? Jun 19 2017
Regeneron Expected to Report Healthy Revenue Growth in 2017 Jun 19 2017
Health Care Stocks Are Crushing the S&P 500 Jun 19 2017
Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact" Jun 16 2017
Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug Jun 15 2017
Start Your Morning With a Cup of Coffee and an Ounce of Dengue Prevention Jun 14 2017
Sanofi to invest further in biologics Jun 14 2017
10 High-Quality Foreign-Stock Bargains Jun 14 2017
Seres Therapeutics' Stock Up as SER-109 Moves to Phase III Jun 13 2017
Intercept (ICPT) Releases Data from Phase II Flint Trial Jun 13 2017
Featured Company News - Data Indicates Sanofi's Soliqua(R) 100/33 Helps in Lowering Hba1c Levels in... Jun 13 2017
Are Sanofi, Gilead In A Bidding War Over This Small-Cap Biotech? Jun 12 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK